MedTrace Logo

Ketamine vs Hydromorphone

NCT03001843 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2021-03-09

Study results available
· View outcomes & findings →

Summary

This study will help to determine if investigators can minimize narcotic use in laparoscopic gastric bypass patients while maintaining adequate pain control. This will allow investigators to minimize the negative side effects of narcotics which is a goal in this population.

Conditions

  • Laparoscopic Gastric Bypass
  • Obesity
  • Pain, Postoperative

Interventions

DRUG

Ketamine

Anesthesia of only Ketamine

DRUG

Narcotics

The narcotic group will receive no ketamine but rather a more standard anesthetic

BEHAVIORAL

pain scale

0-10 pain scale. 0 = no pain and 10 = worst pain

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • David M Smyth, MSN · Shands Hospital at the University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-22
Primary Completion
2018-12-21
Completion
2018-12-21
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03001843 on ClinicalTrials.gov